Intellectual Property India Publishes Patent Application for 'Combinations Of Lsd1 Inhibitors And Menin Inhibitors For Treating Cancer' Filed by Oryzon Genomics, S. A.

MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202547058822 A) filed by Oryzon Genomics, S. A., Madrid, on June 19, for 'combinations of lsd1 inhibitors and menin inhibitors for treating cancer.'

Inventor(s) include Sacilotto, Natalia; and Soliva Soliva, Robert.

The application for the patent was published on June 27, under issue no. 26/2025.

According to the abstract released by the Intellectual Property India: "The instant invention relates to combinations of an LSD1 inhibitor (or a pharmaceutically acceptable salt thereof) and a Menin inhibitor (or a pharmaceutically acceptable salt thereof). The combinations are particularly useful for treating cancer, including hematological cancers, such as acute myeloid leukemia or myelodysplastic syndrome."

The patent application was internationally filed on Nov. 24, 2023, under International application No.PCT/EP2023/083043.

Disclaimer: Curated by HT Syndication.